Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
nsaids alendronate

increases risk of gastrointestinalirritation

Unknown Study
nsaids bisphosphonates

increases risk of gastrointestinalirritation

Unknown Study
nsaids bisphosphonates

increases risk of renalimpairment

Unknown Study
nsaids clodronate

increases risk of renalimpairment

Unknown Study
nsaids deferasirox

increases risk of gastrointestinalbleeding

Unknown Theoretical
nsaids deferiprone

increases exposure

Unknown Theoretical
nsaids ibandronate

increases risk of gastrointestinalirritation

Unknown Study
nsaids ironchelators

increases risk of gastrointestinalbleeding

Unknown Theoretical
obeticholicacid coumarins

decreases anticoagulant effect

Unknown Study
obeticholicacid theophylline

increases exposure

Unknown Theoretical
obeticholicacid tizanidine

increases exposure

Unknown Theoretical
obeticholicacid warfarin

decreases anticoagulant effect

Unknown Study
octreotide oralciclosporin

decreases absorption

Unknown Anecdotal
octreotide telotristatethyl

decreases exposure

Unknown Study
olanzapine levodopa

decreases effects

Unknown Anecdotal
olaparib aliskiren

increases exposure

Unknown Theoretical
olaparib antihistamines,non-sedating

increases exposure

Unknown Theoretical
olaparib colchicine

increases exposure

Unknown Theoretical
olaparib dabigatran

increases exposure

Unknown Theoretical
olaparib digoxin

increases exposure

Unknown Theoretical
olaparib docetaxel

increases exposure

Unknown Theoretical
olaparib everolimus

increases exposure

Unknown Theoretical
olaparib fexofenadine

increases exposure

Unknown Theoretical
olaparib loperamide

increases exposure

Unknown Theoretical
olaparib paclitaxel

increases exposure

Unknown Theoretical
olaparib sirolimus

increases exposure

Unknown Theoretical
olaparib statins

increases exposure

Unknown Theoretical
olaparib talazoparib

increases exposure

Unknown Theoretical
olaparib taxanes

increases exposure

Unknown Theoretical
olaparib thrombininhibitors

increases exposure

Unknown Theoretical
olaparib topotecan

increases exposure

Unknown Theoretical
olaparibpotentially combinedhormonalcontraceptives

affects efficacy

Unknown Theoretical
omeprazole cilostazol

increases exposure

Unknown Study
opicapone adrenalineepinephrine

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone loperamide

increases exposure

Unknown Study
opicapone noradrenalinenorepinephrine

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone repaglinide

increases exposure

Unknown Study
opicapone sympathomimetics,inotropic

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone sympathomimetics,vasoconstrictor

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opioids drugsthatcauseserotoninsyndrome

increases risk of serotoninsyndrome

Unknown Theoretical
opioids seetablep

increases risk of serotoninsyndrome

Unknown Theoretical
oralaluminiumhydroxide chenodeoxycholicacid

decreases absorption

Unknown Study
oralaluminiumhydroxide theactivemetaboliteoforalbaloxavirmarboxil

decreases concentration

Unknown Theoretical
oralantacids chloroquine

decreases absorption

Unknown Theoretical
oralantacids deflazacort

decreases absorption

Unknown Theoretical
oralantacids ibandronate

decreases absorption

Unknown Theoretical
oralantacids immediatereleasetablets

decreases absorption

Unknown Theoretical
oralantacids levothyroxine

decreases absorption

Unknown Anecdotal
oralantacids oralacalabrutinib

decreases exposure

Unknown Study
oralantacids oralantimalarials

decreases absorption

Unknown Theoretical
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.